AISAP Cardio vs iCAC Device

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Aisap
VS
by Bunkerhill Health

AI Verdict

AISAP Cardio provides comprehensive cardiac diagnostic assessments and measurements using point-of-care ultrasound for conditions like structural heart disease and heart failure. In contrast, Bunkerhill Health's iCAC Device analyzes routine chest CT scans to detect and quantify coronary artery calcium, aiding in cardiovascular risk assessment. While both are FDA-cleared AI tools for cardiology, they utilize different imaging modalities and focus on distinct aspects of cardiovascular disease detection.

Choose AISAP Cardio if…

Choose AISAP Cardio if you require immediate, comprehensive cardiac diagnostic assessments at the point of care. This tool is ideal for clinicians needing rapid AI-powered interpretation of bedside ultrasound scans to detect structural heart disease and heart failure, including detailed measurements of valvular pathologies and ventricular function.

View AISAP Cardio →

Choose iCAC Device if…

Choose iCAC Device if your primary goal is to opportunistically identify and quantify coronary artery calcium from existing, routine non-contrast chest CT scans. This solution is best suited for healthcare systems looking to leverage previously acquired imaging data to assess cardiovascular disease risk without requiring additional dedicated cardiac scans.

View iCAC Device →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AISAP Cardio iCAC Device
Pricing Not publicly available Contact for pricing
Deployment Cloud-based SaaS platform Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform).
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AISAP Cardio

AISAP Cardio is designed for direct, interactive use at the point of care, empowering both novice and experienced clinicians, including non-cardiologists, to perform and interpret complex cardiac assessments. Its real-time feedback and automated reporting streamline the workflow, making advanced diagnostics accessible at the bedside.

Clinical Value

Tie

Both tools offer significant and distinct clinical value. AISAP Cardio provides comprehensive, real-time cardiac diagnostic assessments at the point of care for a range of conditions. iCAC Device excels in opportunistic cardiovascular risk stratification by leveraging existing CT scans, leading to earlier detection and intervention, further supported by a CMS reimbursement pathway.

Pricing & Value

iCAC Device

While both tools lack publicly available pricing, iCAC Device has a notable advantage with its established CMS reimbursement pathway for algorithmic analysis of coronary artery calcium (CAC) and aortic valve calcium (AVC). This provides a clear mechanism for financial recovery and demonstrates recognized economic value within the healthcare system.

Enterprise Readiness

AISAP Cardio

AISAP Cardio explicitly states its use of a 'secure, HIPAA-compliant and ISO-certified cloud' and is described as a 'vendor-agnostic and scalable solution' with seamless integration into EHR/EMR and PACS. This indicates a robust foundation for enterprise deployment and adherence to critical healthcare data security standards.

Innovation

iCAC Device

While both are innovative, Tool B's ability to opportunistically identify and quantify coronary artery calcium from routine, non-gated chest CT scans (scans not originally ordered for cardiac assessment) represents a particularly novel approach. This leverages already acquired data for widespread cardiovascular risk assessment without additional patient burden or imaging.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offer sufficient public information regarding dedicated support channels, comprehensive documentation, or structured training programs for either tool. Therefore, it is not possible to distinguish between them on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AISAP Cardio iCAC Device
Name AISAP Cardio iCAC Device
Company Aisap Bunkerhill Health
Description FDA-cleared, AI-powered point-of-care ultrasound (POCUS) software platform that provides rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure at the bedside. FDA-cleared AI algorithm that detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection.
Key Functionality AI-powered interpretation for early cardiac disease detection, comprehensive cardiac ultrasound software package, automated generation of analyses, interpretations, and reports, assessment of valvular pathologies, measurement of Left Ventricle Ejection Fraction (LVEF), measurement of right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter. Estimates presence and quantity of coronary artery calcium (CAC), analyzes routine, non-contrast, non-gated chest CT scans, utilizes deep-learning algorithms for analysis, provides adjunctive information to radiologists, outputs visual representation of estimated CAC segmentation, delivers exact and four-category quantitative estimates of CAC burden in Agatston units.
Primary Data Source Point-of-care ultrasound (POCUS) Routine, non-contrast, non-gated chest CT scans

Videos

Demos, reviews, and walkthroughs featuring AISAP Cardio and iCAC Device.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AISAP Cardio is an AI-powered point-of-care ultrasound (POCUS) software platform that analyzes cardiac ultrasound images. In contrast, the iCAC Device is an AI algorithm that detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans.
AISAP Cardio provides rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure, including valvular pathologies and Left Ventricle Ejection Fraction (LVEF). The iCAC Device estimates the presence and quantity of coronary artery calcium (CAC) from CT scans, aiding in early cardiovascular disease detection.
AISAP Cardio is a cloud-based SaaS platform designed for seamless integration with existing clinical workflows, EHR/EMR, and PACS systems. The iCAC Device, a Software as a Medical Device (SaMD), integrates with PACS or a DICOM router and supports EHR integration via the Carebricks platform.
AISAP Cardio automatically generates analyses, interpretations, and reports, including measurements of LVEF, right and left ventricular dimensions, atrial areas, ascending aorta diameter, IVC diameter, and assessment of valvular pathologies. The iCAC Device outputs visual representations of estimated CAC segmentation and delivers exact and four-category quantitative estimates of CAC burden in Agatston units.
AISAP Cardio's primary application is for rapid, comprehensive cardiac diagnostic assessments and measurements at the bedside, supporting early detection of structural heart disease and heart failure. The iCAC Device's main use is to opportunistically identify and quantify coronary artery calcium from existing CT scans to assist in early cardiovascular disease detection.
AI Tool Finder
AI-powered search. Results may not be comprehensive.